Correlation coefficients and respective P values of each DA matrix test with the full-loci dataset are shown in Table 2. Most coefficients of marker pairs are above 0.20 and respective P values are all less than 0.05, suggesting distance measurements by different markers are overall positively correlated.
Penalized regression methods shrink down to zero the coefficient of markers that have little apparent effect on the trait of interest, resulting in a parsimonious subset of what we hope are true pertinent predictors.
Regression coefficients of the markers were calculated as the means of their posterior distributions.
Regression coefficients of all markers are zero at the start of the algorithm.
If the coefficients of the markers are set to zero or a low value in the training phase, they are excluded from the model and their genotype information is not required during the breeding phase.
To further assess the combined effects of both markers, we generated an equation, combined risk score = exp [ 0.054 x log square transformed values of lipocalin-2) + (0.024 x log square transformed values of MMP-9 ] MMP-9 ]on the linear regression model using the coefficients of each marker determined basede multivariate monel including each marker (contheuous) and adjustment variablinear
These models can be described by the following general model: 1 where y is the vector of trait phenotypes, X is a known incidence matrix that relates the vector of non-genetic, "fixed" effects to y, T= M− E(M), M is a matrix of marker covariates, α is the vector of random, partial-regression coefficients of the marker covariates, and e is a vector of residuals.
Comparison of the marker orders between three component maps and the consensus map indicated high degree of accordance across all seven chromosomes as evidenced from the Spearman's rank correlation coefficient (r) of marker orders (Additional file 2: Table S6).
Based on the relationship of the regression coefficients of four-biochemical markers, ALP, bilirubin, albumin and platelet count, we developed a new fibrosis-cirrhosis index for the prediction of HCV disease progression from initial fibrosis stage to end stage cirrhosis.
The cumulative genetic risk for each individual was calculated using the estimated regression coefficients of the 350 markers included in the model, providing a measure of the extent to which common allelic variation (and the variables in the model) explained disease status in this dataset.
